About: cancer

France takes Roundup weed-killer off market after court ruling

French authorities on Tuesday (15 January) banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into account when clearing the widely used herbicide.

Disparities remain on how to tackle lung cancer in Europe, report says

Enhanced prevention measures, especially against tobacco and electronic cigarettes, combined with access to innovative treatments can help tackle rising lung cancer cases in Europe, a new study funded by the industry has found.

Romanian health minister: Prevention and innovative drugs to kill cancer

In order to face the rising cancer incidence across Europe, governments should prioritise prevention policies, as well as access to innovative medicines under an EU-wide plan, Romanian Health Minister Sorina Pintea told EURACTIV.com in an interview.

Together we can change the future of cancer

With momentum growing for a European Cancer Plan, there is a real opportunity to make a difference for cancer patients in Europe in the next term of the European institutions, writes Deepak Khanna.

MEP: Need for an EU-wide cancer plan to ensure long-term pharma innovation

The creation of an EU cancer plan will improve EU citizens’ medical needs and access but will also simultaneously help bring innovations to the market, through enhanced collaboration among stakeholders, according to Belgian MEP Lieve Wierinck.

Sakharov Prize nominees include NGOs in the Mediterranean

The nominees for the 2018 Sakharov Prize for Freedom of Thought have been announced on Thursday (27 September), including Oleg Sentsov, the Ukrainian film director imprisoned in Russia and NGOs saving lives of migrants in the Mediterranean. Since 1988, THE...

US lawyers confident to win more Glyphosate-related legal cases against Monsanto

In a public hearing at the European Parliament on Wednesday (5 September), two US attorneys said they were confident they would win further legal cases against Monsanto, following a landmark San Francisco trial in August that ordered the US company to pay plaintiff Dwayne Johnson $289 million in damages.

European Medicines Agency launches review of recalled heart drug

The European Medicines Agency (EMA) said Thursday it is conducting a review of the health effects on patients of a widely used blood pressure medication recalled around the world last month.

Serbia launches probe into 1999 NATO bombing

Almost two decades after the NATO bombing of Serbia, local authorities there have launched an investigation to determine whether depleted uranium bombs were used, which could explain in surge in autoimmune diseases. EURACTIV.rs reports.

European Commission urged to deliver on new EDCs strategy

MEPs and civil society representatives urged the European Commission on 24 May to act soon on defining a new strategy following the rejection by the European Parliament last autumn of its endocrine disruptor chemicals (EDC) definition.

Glyphosate has adverse health effects from doses considered safe, study shows

Glyphosate, the chemical found in the world’s most widely used weed-killer, can have disruptive effects on sexual development, genes and beneficial gut bacteria at doses considered safe, according to a study presented at the European Parliament on Wednesday (16 May).

MEPs step up action to protect terminally ill workers in the EU

A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.

Exposure to carcinogens at work in EU’s crosshairs

The EU Agency for Safety and Health at Work has launched a joint campaign with the European Commission and the Bulgarian EU Presidency aimed at raising awareness of dangerous substances at work while sounding the alarm about the surging costs related to cancer.

UK cancer patients must have access to radiotherapy after Euratom exit, warn MPs

MPs have demanded guarantees that UK cancer patients will not lose access to new radiotherapy treatments because of the UK’s withdrawal from the EU’s treaty on nuclear materials.

Huge inequality in access to cancer care across EU

Europeans face extreme inequality in access to diagnosis and treatment for lung cancer, a report published this week revealed. Experts have called for a harmonised approach to cancer care and greater efforts to promote preventive policies.

EU lawmakers push for better outcomes for metastatic breast cancer patients

Metastatic breast cancer (MBC) kills half a million women in the EU every year, yet progress on the quality of life and survival time of MBC patients remains elusive. MEPs addressed the need to improve patient outcomes with a policy roadmap launched on Tuesday (17 October).

The key to reducing EU cancer deaths

The European Commission is on track to miss its target of decreasing cancer deaths by 15% by 2020. But a focus on thrombosis, the subject of a global awareness campaign today, could turn things around.

EU agency OK’d 39 cancer drugs without evidence they work, study shows

The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).

Closing the gap on metastatic breast cancer

October is breast cancer awareness month. The pink ribbon movement has achieved progress in spreading awareness and pushing for widespread cancer screening.

MEPs adopt stricter limits on carcinogens in the workplace

EU lawmakers on Wednesday (30 August) voted on tough new exposure limits to carcinogenic substances in the workplace, in a move they hope will save more than 100,000 lives over the next 50 years.

Commission: Plain tobacco packaging does not damage the economy

A European Commission spokesperson has told EURACTIV.com that any loss in the tobacco industry’s turnover arising from health warnings or plain packaging should be offset against the cost of treating people with smoking-related diseases.

EU leaps forward in attempt to ban carcinogens at work

After more than ten years of inaction, European lawmakers have taken the first step to update EU laws related to the prevention of occupational cancers that are believed to cause 100,000 deaths every year. Trade unions hailed the EU’s decision, which brings an end to years of stalemate.